Zika Virus Vaccines

The Live-Attenuated vaccine is developed to the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, definition of E dimers as the key antigenic target, and deep understanding of neutralization mechanisms help to develop the vaccine.

  • Zika Virus Vaccine Development
  • Zika Virus Vaccines Recent Research
  • Zika Virus Vaccines Clinical Trials
  • Zika Virus Vaccine in Pregnant Women
  • Purified Inactivated Vaccine
  • DNA Vaccine
  • Live Attenuated Vaccine
  • DNA and mRNA Vaccine

Related Conference of Zika Virus Vaccines

March 21-22, 2019

32nd International Conference on Vaccines and Immunization

Hotel Holiday Inn, Aurelia Rome, Italy
June 13-14, 2019

2nd International Conference on Vaccine Research

Paris, France
August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland, New Zealand
October 25-26, 2019

37thVaccination, Immunization & Antibiotics

Vancouver, Canada
November 12-13, 2019

35th World Vaccines & Immunization Congress

Brisbane, Australia

Zika Virus Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in